ORGANIZATION TO ACHIEVE SOLUTIONS IN SUBSTANCE-ABUSE

 

 
 
 
 

    

PUBLICATIONS

  

 

  

   
1: Sylvestre D.  

Hepatitis C treatment in drug users: perception versus evidence.
Eur J Gastroenterol Hepatol. 2006 Feb;18(2):129-30. No abstract available.

Click here

 
2: Sylvestre DL.  

Approaching treatment for hepatitis C virus infection in substance users.
Clin Infect Dis. 2005 Jul 1;41 Suppl 1:S79-82.

Click here

 
3: Sylvestre DL, Litwin AH, Clements BJ, Gourevitch MN.  

The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone.
J Subst Abuse Treat. 2005 Oct;29(3):159-65.

Click here

 
4: Sylvestre DL.  

Treating hepatitis C virus infection in active substance users.
Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S321-4.

Click here

 
5: Sylvestre DL, Loftis JM, Hauser P, Genser S, Cesari H, Borek N, Kresina TF, Seeff L, Francis H.  

Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care.
J Urban Health. 2004 Dec;81(4):719-34.

Click here

 
6: Sylvestre DL, Clements BJ.  

The utility of indirect predictors of hepatitis C viremia.
Drug Alcohol Depend. 2004 Apr 9;74(1):15-9.

Click here

 
7: Sylvestre DL, Disston AR, Bui DP.  

Vogt-Koyanagi-Harada disease associated with interferon alpha-2b/ribavirin combination therapy.
J Viral Hepat. 2003 Nov;10(6):467-70.

Click here

 
8: Sylvestre DL.  

Treating hepatitis C in methadone maintenance patients: an interim analysis.
Drug Alcohol Depend. 2002 Jul 1;67(2):117-23.

Click here